Granted Patent
B2
US 9,623,078 · App. 14/436,906 · Granted Apr 18, 2017
Method for treating cardiac infarction using HMGB1 fragment
Inventors:
Katsuto Tamai (Osaka, JP); Sokichi Kamata (Osaka, JP); Yasufumi Kaneda (Osaka, JP); Shigeru Miyagawa (Osaka, JP); Yoshiki Sawa (Osaka, JP); Takehiko Yamazaki (Osaka, JP)
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A fragment peptide having a proper length composed of a part of an HMGB1 protein was synthesized and the peptide was confirmed to exhibit therapeutic effects on myocardial infarction.
Claims (1)
1. A method for treating myocardial infarction in a subject, wherein said method comprises administering, to a subject in need of such treatment, an HMGB1 fragment peptide consisting of the amino acid sequence of SEQ ID NO: 3.
Assignments (3)
CHANGE OF NAME
Recorded Sep 18, 2018
From: GENOMIX CO., LTD.
To: STEMRIM INC.
Reel/Frame 047102/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 13, 2015
From: TAMAI, KATSUTO; KAMATA, SOKICHI; KANEDA, YASUFUMI; MIYAGAWA, SHIGERU; SAWA, YOSHIKI
To: OSAKA UNIVERSITY
Reel/Frame 036320/0323 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 13, 2015
From: YAMAZAKI, TAKEHIKO
To: GENOMIX CO., LTD.
Reel/Frame 036320/0340 →
Priority Claims (1)
JP 2012-235785
· Oct 25, 2012
· national
Continuity (1)